This Molecular and Celluar Pathology graduate student event showcases research within the department by faculty, postdoctoral fellows, and Ph.D. students.
Dan Rhodes, PhD
CEO, Strata Oncology
Adjunct Assistant Professor, Department of Pathology, University of Michigan
Dan Rhodes is a scientist and entrepreneur focused on precision medicine in oncology.
He is currently co-founder and CEO of Strata Oncology, a venture-backed company leveraging its state-of-the-art cancer genome sequencing laboratory to accelerate precision medicine clinical trials. From 2012-2015, Dan was Vice President of Oncology for Thermo Fisher Scientific (Life Technologies) where he oversaw the development of cancer sequencing products and pharma companion diagnostic partnerships. From 2006-2012, Dan was co-founder and CEO of Compendia Bioscience, a University of Michigan spinoff formed to further develop and commercialize his thesis project, Oncomine™, a cancer genome data-mining platform. Over six years, Compendia grew to 20+ pharma customers, 10,000+ users and nearly $10M in annual revenue, culminating in the acquisition by Life Technologies in 2012. Dan has co-authored 40+ publications and is a co-inventor on 10 patents, including the discovery of gene fusions as a genetic cause of prostate cancer. He received the Weintraub Award, the AACR Team Science Award and was recognized by Crain’s Detroit as a Mergers and Acquisitions Deal of the Year Finalist. Dan serves on the oversight committee for the Michigan Translational Research and Commercialization (MTRAC) Program and on the Advisory Boards for eLab Ventures and the Monroe-Brown Biomedical Seed Fund. Dan received both a Bachelor of Science in Molecular Biology and a Doctorate in Bioinformatics from The University of Michigan.
9 AM — Student and faculty talks
10:50 AM — Break
11 AM — Keynote Speaker
Noon — Lunch/Poster session
1:30 — Student and faculty talks
4:00 PM — Break
4:15 PM — Career Panel
4:45 PM — Awards
For more information, contact Laura Labut.